Needham & Company
View Older Stories
-
SS&C Technologies Holdings, Inc. (SSNC) PT Raised to $105 at Needham
-
Axon to Release Third Quarter 2026 Earnings on November 5, 2026
-
Applied Materials falls as investor day fallout continues
-
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
-
Lam Research (LRCX) PT Lowered to $290 at Needham
-
Needham reiterates Buy rating on Nvidia with $300 target
-
Informa TechTarget to Announce Third Quarter 2026 Financial Results; Participate in Upcoming Investor Conference
-
Blank Rome Marks 10th Annual State of the Cannabis Industry Conference
-
VRNS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Varonis to Proofpoint
-
VRNS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Varonis to Proofpoint
-
Equifax (EFX) PT Raised to $210 at Needham
-
Needham Downgrades Netflix (NFLX) to Hold
-
Needham: 'We continue to expect SMCI's backlog strength to continue'
-
Tripadvisor to Host Third Quarter 2026 Financial Results Conference Call on November 5, 2026
-
SharkNinja Puts Its Fans in the Spotlight with Two New Creator Programs, First Fans and SharkNinja Storytellers
-
Centrus Energy Corp. (LEU) PT Lowered to $206 at Needham
-
Walker & Dunlop: Institutional Capital fuels 74% Surge in Seniors Housing Transactions
-
Needham on Carter's (CRI): 'we see potential for the stock to drift lower'
-
Needham Reiterates Buy Rating on Red Cat Holdings Inc. (RCAT)
-
EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
-
Needham Starts Kontoor Brands (KTB) at Hold
-
Needham Starts Urban Outfitters, Inc. (URBN) at Buy
-
Needham Starts Boot Barn (BOOT) at Buy
-
Needham Starts Victoria Secret (VSXY) at Buy
-
Needham Starts Gap, Inc. (GAP) at Hold
-
Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK
-
Needham Reiterates Buy Rating on Rocket Lab USA (RKLB)
-
Needham Downgrades Varonis Systems (VRNS) to Hold
-
NB Bancorp, Inc. Reports Third Quarter 2026 Financial Results, Declares Quarterly Cash Dividend
-
Recursion prices $200M stock offering at $3.25 per share
-
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
-
Taiwan Semi (TSM) PT Raised to $560 at Needham
-
Needham Starts CAMP4 Therapeutics Corp (CAMP) at Buy
-
Mighty Therapeutics Reports Business Highlights, Barth Syndrome Commercial Launch Update, and Pipeline Progress
-
SharkNinja Announces Third Quarter 2026 Earnings Release and Conference Call Date
-
Liquidia Technologies (LQDA) PT Lowered to $58 at Needham
-
Starling Oncology (STLN) PT Raised to $9 at Needham
-
Needham Reiterates Buy Rating on Workday (WDAY)
-
Integrative Healthcare Symposium (IHS) Names David Perlmutter, MD, and Jeffrey Bland, PhD as Chair and Vice Chair for IHS 2027
-
SentinelOne Inc (S) PT Raised to $31 at Needham
-
Synopsys (SNPS) PT Raised to $620 at Needham
-
Enovis Corp (ENOV) PT Lowered to $34 at Needham
-
Vaxcyte closes $1.15B public offering of stock and notes
-
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional
-
CrowdStrike (CRWD) PT Raised to $310 at Needham
-
Zeta Global Holdings Corp (ZETA) PT Raised to $40 at Needham
-
Needham: 'Traffic Tracker: Bullish for RDDT 3Q26 User and Rev Growth'
-
Needham Reiterates Hold Rating on Elastic NV. (ESTC)
-
Sezzle to Announce Third Quarter 2026 Results and Participate in Upcoming Investor Conferences
-
Needham Downgrades Pacira Pharmaceuticals (PCRX) to Hold


